Menu
Recruiting NCT07747727

Perineal Ultrasound, Post-Void Residual, and Lower-Limb Alignment in Stress Incontinence

Observational Stress Urinary Incontinence in Women

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Stress Urinary Incontinence in Women. Basic parameters: 50 years — 65 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Perineal Ultrasound α/β Angles, Post-Void Residual Volume, and Lower-Limb Alignment in Symptomatic and Asymptomatic Postmenopausal Women With Stress Incontinence.

Overview

Stress urinary incontinence (SUI) in postmenopausal women is traditionally considered a local pelvic floor disorder, but emerging evidence suggests that spinopelvic and lower limb alignment may also contribute to continence mechanisms. Transperineal ultrasound α/β angles and post void residual (PVR) volume are promising imaging markers that might capture this broader biomechanical phenotype. Objective To compare hip ultrasound α/β angles, PVR volume, and lower limb and spinopelvic alignment between symptomatic and asymptomatic postmenopausal women, and to explore within group correlations between PVR and musculoskeletal alignment variables.

Detailed description

We conducted an observational case-control study with coordinated cross sectional analyses of two anonymised datasets from a tertiary urogynecology outpatient clinic in Saudi Arabia. Postmenopausal women (≥50 years) able to stand and walk independently were classified as symptomatic (SUI) if they reported stress related leakage and had an elevated International Consultation on Incontinence Questionnaire-Short Form score, or as asymptomatic controls if they denied leakage and had minimal symptom scores. Primary outcomes were transperineal hip ultrasound α/β angles at rest and during Valsalva, PVR volume, navicular drop test (NDT), spinopelvic parameters (pelvic incidence, pelvic tilt, sacral slope), tibial and femoral torsion, and Q angles. Between group comparisons used parallel parametric and non parametric tests with Holm-Bonferroni correction, and within group correlations between PVR and alignment variables were assessed with Pearson and Spearman coefficients.

Primary outcome measures

  • hip ultrasound parameters [Time frame: At a single study visit (baseline)]
Secondary outcome measures (3)
  • Lower-Limb and Foot Posture Measures [Time frame: At a single study visit (baseline)]
  • Spinopelvic Alignment and Torsion [Time frame: At a single study visit (baseline)]
  • Post-Void Residual Volume [Time frame: At a single study visit (baseline)]

Eligibility criteria

Inclusion Criteria: post menoupausal women, who had at least 12 months of amenorrhea or follicle-stimulating hormone values within the menopausal range and who could stand and walk independently to allow lower-limb and alignment assessments.

\-

Exclusion Criteria:women with urge or mixed incontinence as the dominant symptom, prior pelvic floor or anti-incontinence surgery, severe pelvic organ prolapse (stage 3 or greater), or neurological conditions affecting bladder function or gait, as well as those with hip or spine surgery likely to alter spinopelvic parameters

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Egypt · 1 center
  • out patient clinic, Faculty of Physical Therapy, Benha University — Banhā

Identifiers

NCT: NCT07747727 · PT. BU. EC. 45

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗